665 related articles for article (PubMed ID: 27784538)
41. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
42. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Floreani A; Franchitto A; Onori P; Cazzagon N; Berloco PB; Karlsen TH; Alvaro D; Gaudio E
Am J Pathol; 2018 Mar; 188(3):627-639. PubMed ID: 29248458
[TBL] [Abstract][Full Text] [Related]
43. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
[TBL] [Abstract][Full Text] [Related]
44. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis.
Hazama H; Omagari K; Masuda J; Kinoshita H; Ohba K; Sakimura K; Matsuo I; Isomoto H; Murase K; Murata I; Kohno S
J Clin Lab Anal; 2000; 14(5):208-13. PubMed ID: 11018798
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
[TBL] [Abstract][Full Text] [Related]
46. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
Sebode M; Weiler-Normann C; Liwinski T; Schramm C
Front Immunol; 2018; 9():609. PubMed ID: 29636752
[TBL] [Abstract][Full Text] [Related]
47. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
Björkland A; Lööf L; Mendel-Hartvig I; Tötterman TH
J Immunol; 1994 Sep; 153(6):2750-7. PubMed ID: 8077679
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.
Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J
Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268
[TBL] [Abstract][Full Text] [Related]
49. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.
Schramm C; Lohse AW
Clin Rev Allergy Immunol; 2005 Apr; 28(2):105-14. PubMed ID: 15879617
[TBL] [Abstract][Full Text] [Related]
50. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.
Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
Can J Gastroenterol; 2012 Mar; 26(3):125-9. PubMed ID: 22408762
[TBL] [Abstract][Full Text] [Related]
52. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
54. In vitro production of antimitochondrial antibody by peripheral blood mononuclear cells in patients with primary biliary cirrhosis.
Ishikawa T; Kakumu S; Wakita T; Takayanagi M; Yoshioka K
J Clin Lab Immunol; 1991 May; 35(1):17-25. PubMed ID: 1668286
[TBL] [Abstract][Full Text] [Related]
55. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies.
Hazama H; Omagari K; Masuda J; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
J Gastroenterol Hepatol; 2002 Mar; 17(3):316-23. PubMed ID: 11982703
[TBL] [Abstract][Full Text] [Related]
56. Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis.
Fischer S; Trivedi PJ; Ward S; Greig PD; Therapondos G; Hirschfield GM
Int J Exp Pathol; 2014 Jun; 95(3):209-15. PubMed ID: 24750423
[TBL] [Abstract][Full Text] [Related]
57. Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance.
Preuss B; Berg C; Altenberend F; Gregor M; Stevanovic S; Klein R
Clin Exp Immunol; 2007 Nov; 150(2):312-21. PubMed ID: 17711488
[TBL] [Abstract][Full Text] [Related]
58. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.
Zandanell S; Strasser M; Feldman A; Tevini J; Strebinger G; Niederseer D; Pohla-Gubo G; Huber-Schönauer U; Ruhaltinger S; Paulweber B; Datz C; Felder TK; Aigner E
J Intern Med; 2020 Apr; 287(4):395-404. PubMed ID: 31802567
[TBL] [Abstract][Full Text] [Related]
59. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
